AVITA Medical, Inc. (RCEL)

11.20 +0.26 (+2.38%) USD  |  NASDAQ  |  Sep 04, 16:00
11.16 -0.04 (-0.36%) After-Hours: 20:00
More

AVITA Medical Cash and Short Term Investments (Annual) : 18.18M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for RCEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1999. Start Trial.
Date Value
December 31, 2025 18.18M
December 31, 2024 35.88M
December 31, 2023 89.06M
December 31, 2022 79.34M
June 30, 2021 110.95M
June 30, 2020 73.84M
June 30, 2019 20.34M
June 30, 2018 10.95M
June 30, 2017 2.908M
June 30, 2016 3.642M
June 30, 2015 2.280M
June 30, 2014 3.444M
June 30, 2013 9.718M
June 30, 2012 8.437M
Date Value
June 30, 2011 13.63M
June 30, 2010 3.434M
June 30, 2009 3.134M
June 30, 2008 8.507M
June 30, 2007 10.44M
June 30, 2006 6.373M
June 30, 2005 7.051M
June 30, 2004 2.530M
June 30, 2003 2.015M
December 31, 2002 2.221M
December 31, 2001 4.004M
December 31, 2000 4.536M
December 31, 1999 2.801M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. 142.82M
Iovance Biotherapeutics, Inc. 296.98M
Amgen, Inc. 9.129B
Editas Medicine, Inc. 146.64M
Arcus Biosciences, Inc. 981.00M